DOASENSE GmbH -- Technology - Pioneering Point-of-Care Testing for DOACs

Go to content
DOASENSE Technology Image

Our Technologies

Our sophisticated technologies for assessing DOAC in urine provide meaningful data to health care professionals and consumers, all in an easy, rapid assessment process
  • DOASENSE has developed technologies for assessing the presence or absence of oral direct Factor Xa as well as Thrombin inhibitors in urine samples through specific colors

  • The colors (e.g. on dipsticks) can be identified by the naked eye within a few minutes

  • Different color combinations are used for Factor Xa and Thrombin inhibitors

The DOAC Dipstick Point-of-Care Test:

How the DOAC Dipstick works:
DOASENSE Technology Animation

Listen to what opinion leaders think about DOASENSE's solutions:    (in German)

Our Data

Global Study Data (13 Centers), from:
Harenberg J, et al., Clin Chem Lab Med. 2016 Feb 1; 54(2):275-83
Study Data
Our Intellectual Property

DOASENSE has compiled and owns a broad portfolio of international intellectual property for protecting its proprietary approaches to DOACs testing.
NOTE: DOASENSE(TM) products may not be available or approved in your country.

Copyright (c) 2016-2018 DOASENSE GmbH. All rights reserved.
Back to content